Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts
Pansclerotic morphea (PSM) is a rare skin disease characterized by progressive stiffening of the skin with or without the typical superficial skin changes usually seen in morphea (localized scleroderma). Standard therapy, consisting of a combination of systemic glucocorticoids and methotrexate or my...
Main Authors: | Sarah Ventéjou, Agnes Schwieger-Briel, Rebecca Nicolai, Stephanie Christen-Zaech, Caroline Schnider, Michael Hofer, Sofia Bogiatzi, Daniel Hohl, Fabrizio De Benedetti, Marie-Anne Morren |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.656407/full |
Similar Items
-
Pansclerotic morphea: A male child with hemiatrophy of lower limb
by: Malay K Dasgupta, et al.
Published: (2014-01-01) -
Disabling pansclerotic morphea of childhood with extracutaneous manifestations
by: Mahendra M Kura, et al.
Published: (2013-01-01) -
Adult-onset unilateral disabling pansclerotic morphea
by: Adarshlata Singh, et al.
Published: (2014-01-01) -
Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2
by: Zahra Lotfi, et al.
Published: (2021-10-01) -
Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review
by: Ewelina Ulc, et al.
Published: (2021-09-01)